17.07.2013 Views

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

View Annual Report - Jules Stein Eye Institute

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

steven Nusinowitz, PhD<br />

Associate Professor of Ophthalmology<br />

Co-Director of the Visual Physiology Laboratory<br />

Director of the Live Imaging and<br />

Functional Evaluation (LIFE) Core<br />

Member of the <strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong><br />

ReseaRch summaRy<br />

Mechanisms of Retinal Degeneration<br />

Dr. Nusinowitz’s primary research interest is focused on<br />

understanding the cellular contributions to noninvasive<br />

measures of visual function and defining the sites and<br />

mechanisms of disease action in inherited retinal and<br />

visual pathway disorders. His main approach to gaining<br />

an understanding of the site and underlying mechanism<br />

of disease action in humans is to study the patterns of<br />

electrophysiological and psychophysical responses<br />

obtained from mice in which the disruption of different<br />

cells or pathways in the visual system are specifically<br />

targeted by genetic manipulation. By comparing the<br />

patterns of responses in human disease with the<br />

patterns of responses from rodents with targeted<br />

cellular disruption, Dr. Nusinowitz is able to test hypotheses<br />

about the underlying pathophysiology in human<br />

disease and to provide a mechanism for the development<br />

of specific diagnostic tools that are sufficiently<br />

sensitive for early detection and better diagnosis of<br />

clinical disease.<br />

Public Service<br />

Editorial Board Service, Current <strong>Eye</strong> Research and<br />

Investigative Ophthalmology and Visual Science<br />

Grant Reviewer, Foundation Fighting Blindness and<br />

Medical Research Council of Canada<br />

Scientific Advisor: The Mouse Mutant Resource,<br />

The Jackson Laboratory; Novartis Pharmaceuticals;<br />

Allergan, Inc.; and Revision Therapeutics, Inc.<br />

Reviewer for many scientific journals<br />

Research Grants<br />

California <strong>Institute</strong> for Regenerative Medicine:<br />

Development of a Stem Cell-Based Transplantation Strategy<br />

for Treating Age-Related Macular Degeneration (Principal<br />

Investigator: Gabriel H. Travis, MD, with other investigators),<br />

11/1/09–10/31/12<br />

National <strong>Institute</strong>s of Health/National <strong>Eye</strong> <strong>Institute</strong>:<br />

<strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong> Core Grant for Vision Research,<br />

for shared-use core facilities among investigators at<br />

the <strong>Jules</strong> <strong>Stein</strong> <strong>Eye</strong> <strong>Institute</strong> (Module Co-Director),<br />

3/1/10–2/28/15<br />

UCLA/Foundation Fighting Blindness Center Grant:<br />

Module I: Clinical Characterization and Correlation With<br />

Molecular Genetic Studies of Individuals With Suspected<br />

Stargardt Disease (Co-Investigator), 7/1/10–6/30/13<br />

Research to Prevent Blindness (Unrestricted Department<br />

Grant): Characterizing Visual Function in HIV-infected<br />

Patients (Principal Investigator), 4/25/11–4/1/12<br />

Faculty | Nusinowitz 57

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!